Regulation of Drosophila embryonic tracheogenesis by dVHL and hypoxia  by Mortimer, Nathan T. & Moberg, Kenneth H.
Developmental Biology 329 (2009) 294–305
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyRegulation of Drosophila embryonic tracheogenesis by dVHL and hypoxia
Nathan T. Mortimer, Kenneth H. Moberg ⁎
Department of Cell Biology, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA⁎ Corresponding author.
E-mail address: kmoberg@cellbio.emory.edu (K.H. M
0012-1606/$ – see front matter © 2009 Elsevier Inc. Al
doi:10.1016/j.ydbio.2009.03.001a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 5 September 2008
Revised 27 January 2009
Accepted 3 March 2009
Available online 11 March 2009
Keywords:
Drosophila
Trachea
Hypoxia
dVHL
Archipelago
Sima
FGF signalingThe tracheal system of Drosophila melanogaster is an interconnected network of gas-ﬁlled epithelial tubes
that develops during embryogenesis and functions as the main gas-exchange organ in the larva. Larval
tracheal cells respond to hypoxia by activating a program of branching and growth driven by HIF-1α/sima-
dependent expression of the breathless (btl) FGF receptor. By contrast, the ability of the developing
embryonic tracheal system to respond to hypoxia and integrate hard-wired branching programs with sima-
driven tracheal remodeling is not well understood. Here we show that embryonic tracheal cells utilize the
conserved ubiquitin ligase dVHL to control the HIF-1 α/sima hypoxia response pathway, and identify two
distinct phases of tracheal development with differing hypoxia sensitivities and outcomes: a relatively
hypoxia-resistant ‘early’ phase during which sima activity conﬂicts with normal branching and stunts
migration, and a relatively hypoxia-sensitive ‘late’ phase during which the tracheal system uses the dVHL/
sima/btl pathway to drive increased branching and growth. Mutations in the archipelago (ago) gene, which
antagonizes btl transcription, re-sensitize early embryos to hypoxia, indicating that their relative resistance
can be reversed by elevating activity of the btl promoter. These ﬁndings reveal a second type of tracheal
hypoxic response in which Sima activation conﬂicts with developmental tracheogenesis, and identify the
dVHL and ago ubiquitin ligases as key determinants of hypoxia sensitivity in tracheal cells. The identiﬁcation
of an early stage of tracheal development that is vulnerable to hypoxia is an important addition to models of
the invertebrate hypoxic response.© 2009 Elsevier Inc. All rights reserved.IntroductionThe development and survival of an organism are dependent on
its ability to adapt to changing environmental conditions. Responses
to some environmental changes, for example in nutrient availability,
temperature, or oxygen concentration, involve alterations in pat-
terns of gene expression that allow the organism to survive periods
of environmental stress. In metazoan cells, the cellular response to
reduced oxygen is mediated primarily by the HIF (hypoxia inducible
factor) family of transcription factors, which are heterodimers
composed of α and β subunits belonging to the bHLH Per-ARNT-
Sim (bHLH-PAS) protein family (reviewed in Kaelin and Ratcliffe,
2008). The HIF-1 αβ heterodimer is the primary oxygen-responsive
HIF in mammalian cells and binds to a speciﬁc DNA sequence
termed hypoxia response element (HRE) present in the promoters
of target genes involved in energy metabolism, angiogenesis,
erythropoiesis, and autophagy (Manalo et al., 2005). HIF-1 activity
is inhibited under normoxic conditions by two hydroxylase enzymes
that use dioxygen as a substrate for catalysis to hydroxylate speciﬁc
proline or aspartate residues in the HIF-1α subunit (reviewed in
Kaelin and Ratcliffe, 2008). These modiﬁcations limit HIF-1 activity
by either reducing HIF-1α levels or inhibiting its ability to activateoberg).
l rights reserved.HRE-containing target promoters. One of these inhibitory mechan-
isms involves the 2-oxoglutarate/Fe(II)-dependent HIF-1 prolyl
hydroxylase (HPH), which attaches a hydroxyl group onto each of
two conserved proline residues in the oxygen-dependent degrada-
tion domain (ODD) of mammalian HIF-1α. These modiﬁcations
create a binding site in the HIF-1α ODD for the Von Hippel-Lindau
(VHL) protein, the substrate adaptor component of a ubiquitin ligase
that subsequently polyubiquitinates HIF-1α and targets it for
degradation by the proteasome (reviewed in Kaelin, 2005). This
degradation mechanism operates constitutively in normoxia and is
epistatic to otherwise wide spread expression of HIF-1α mRNA. HIF-
1α protein is also modiﬁed by a second oxygen-dependent
hydroxylase termed Factor Inhibiting HIF (FIH) that hydroxylates
an asparagine residue in the HIF-1α C-terminal activation domain
(reviewed in Kaelin, 2005). This blocks interaction with the CBP/
p300 transcriptional co-factor and thus further restricts expression
of HIF-1 responsive genes. These parallel O2-dependent hydroxyla-
tion mechanisms by HPH and FIH ensure that HIF-1α levels and
activity remain low in normoxic conditions. However as oxygen
levels become limiting in the cellular environment, rates of
hydroxylation decline and HIF-1α is rapidly stabilized in a form
that dimerizes with HIF-1β, translocates to the nucleus, and
promotes transcription of HRE-containing target genes.
Evidence suggests that invertebrate homologs of HIF-1 are also
regulated in response to changes in oxygen availability (reviewed in
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homolog fatiga (fga) has been shown to genetically antagonize the
HIF-1α homolog similar (sima) during development (Centanin et al.,
2005). The Drosophila VHL homolog dVHL has also been shown to be
capable of binding to human HIF-1α and stimulating its proteasomal
turnover in vitro (Aso et al., 2000). In addition, the Drosophila genome
encodes a well-characterized HIF-1β homolog tango (tgo) (Sonnen-
feld et al., 1997), and two potential FIH homologs (CG13902 and
CG10133; Berkeley Drosophila Genome Project) that have yet to be
analyzed functionally. Spatiotemporal analysis of sima activation
using sima-dependent hypoxia-reporter transgenes has shown that
exposure to an acute hypoxic stress induces Sima most strongly in
cells of the larval and embryonic tracheal system (Arquier et al., 2006;
Lavista-Llanos et al., 2002), while induction of reporter activity in
other tissues requires more chronic exposure to low oxygen (Lavista-
Llanos et al., 2002). The larval tracheal system is composed of an
interconnected network of polarized, epithelial tubes that duct gases
through the organism (reviewed in Ghabrial et al., 2003). As the
trachea acts as the primary gas-exchange organ in the larva, it is thus a
logical site of hypoxia sensitivity. During larval stages, speciﬁc cells
within the tracheal system called ‘terminal cells’ respond to hypoxia
by initiating new branching and growth that results in the extension
of ﬁne, unicellular, gas-ﬁlled tubes toward hypoxic tissues in a manner
somewhat analogous to mammalian angiogenesis (Guillemin et al.,
1996; Jarecki et al., 1999). Studies have shown that sima and its
upstream antagonist fga functionwithin terminal cells to regulate this
process (Centanin et al., 2008). sima is necessary for terminal cell
branching in hypoxia and its ectopic activation, by either transgenic
overexpression or loss of fga, is sufﬁcient to induce excess branching
even in normoxia. These phenotypes have been linked to the ability of
sima to promote expression of the breathless (btl) gene (Centanin et
al., 2008), which encodes an FGF receptor (Klambt et al., 1992) that is
activated by the branchless (bnl) FGF ligand (Sutherland et al., 1996).
This receptor/ligand pair is known to act via a downstream MAP-
kinase signaling cascade to promote cell motility and tubular
morphogenesis in a variety of systems (reviewed in Lubarsky and
Krasnow, 2003). Excessive activation of this pathway within tracheal
cells by transgenic expression of btl is sufﬁcient to drive excess
branching (Lee et al., 1996b). Reciprocally, misexpression of the bnl
ligand in certain peripheral tissues is sufﬁcient to attract excess
terminal cell branching (Jarecki et al., 1999). Indeed production of
secreted factors such as Bnl may be a signiﬁcant part of the physiologic
mechanism bywhich hypoxic cells attract new tracheal growth. Sima-
driven induction of btl in conditions of hypoxia thus allows larval
terminal cells to enter what has been termed an ‘active searching’
mode (Centanin et al., 2008) in which they are hyper-sensitized to
signals emanating from nearby hypoxic non-tracheal cells.
The role of the btl/bnl pathway in tracheal development is not
restricted to hypoxia-induced branching of larval terminal cells. It also
plays a critical, earlier role in the initial development of the embryonic
tracheal system from the tracheal placodes, groups of post-mitotic
ectodermal cells distributed along either side of the embryo that
undergo a process of invagination, polarization, directed migration,
and fusion to create a network of primary and secondary tracheal
branches (reviewed in Ghabrial et al., 2003). btl and bnl are each
required for this process via a mechanism in which restricted
expression of bnl in cells outside the tracheal placode represents a
directional cue for the migration of btl-expressing cells within the
placode. Accordingly, btl expression is normally highest in pre-
migratory and migratory embryonic fusion cells (Ohshiro and Saigo,
1997). In contrast to the larval hypoxic response, sima does not appear
to be required for morphogenesis of the embryonic tracheal system
(Ohshiro and Saigo, 1997). Rather, developmentally programmed
signals in the embryo dictate a stereotyped pattern of btl and bnl
expression that leads to a similarly stereotyped pattern of primary and
secondary tracheal branches (Centanin et al., 2008). The btl/bnlpathway thus responds to developmental signals to drive a ﬁxed
pattern of branching in the embryo, while in the subsequent larval
stage it responds to hypoxia-dependent sima activity to facilitate the
homeostatic growth of larval terminal cells and tracheal remodeling.
Under normal circumstances, developing Drosophila tissues do not
begin to experience hypoxia until the ﬁrst larval stage, when
organismal growth and movement begin to consume more oxygen
than can be provided by passive diffusion alone (Manning and
Krasnow, 1993). As a consequence, the ﬁrst hypoxic challenge
normally occurs after the btl/bnl-dependent elaboration of the
primary and secondary embryonic branches is complete. Thus, the
ability of the larval tracheal system to drive new branching and
remodeling via sima and btl represents the response of a developed
‘mature’ tracheal system to reduced oxygen availability. By contrast
the effect of hypoxia on embryonic tracheal development, which
requires tight spatiotemporal control of Btl signaling to pattern the
tracheal network, is not as well understood. Given that the trachea
does not function as a gas-exchange organ until after ﬂuid is cleared
from the tubes at embryonic stage 17 (Tsarouhas et al., 2007), it may
be that the transcriptional response of embryonic tracheal cells to
hypoxia (Lavista-Llanos et al., 2002) leads to mainly metabolic
changes rather than to a btl-driven program of tubulogenesis and
remodeling. However, if the embryonic tracheal system does utilize
the sima pathway to induce hypoxia-dependent changes in btl gene
transcription, then hypoxic exposure of embryos might be predicted
to produce a situation of competing developmental and homeostatic
inputs that converge on the btl/bnl pathway. The ability of tracheal
cells to integrate such signals may then determine whether or not the
embryonic tracheal system is able to adapt to oxygen stress, or
whether embryonic tracheal development represents a sensitive
period during which the organism's ability to respond to changes in
oxygen levels is inherently limited by a pre-programmed pattern of
developmental gene expression.
Here we show that the embryonic tracheal system utilizes the
dVHL/sima pathway to respond to hypoxia, but that the type and
severity of resulting phenotypes depend on the developmental stage
of exposure. Hypoxic challenge while embryonic tracheal cells are
responding to developmentally programmed btl/bnlmigration signals
disrupts tracheal development and results in fragmented and unfused
tracheal metameres. In contrast, hypoxic challenge at a somewhat
later embryonic stage after fusion is complete results in overgrowth of
the primary tracheal branches and the production of extra secondary
branches. Interestingly, we ﬁnd that the threshold of hypoxia required
to induce tracheal phenotypes in the early embryo is higher than that
required to induce excess branching phenotypes in later embryonic
stages, indicating that tracheal patterning events in the embryo are
relatively resistant to hypoxia. Genetic analysis indicates that both
types of hypoxic tracheal phenotypes – stunting and overgrowth –
require sima and can be phenocopied in normoxia by reducing
expression of the HIF-1α ubiquitin ligase gene dVHL speciﬁcally
within tracheal cells. Moreover, we ﬁnd that reduced dVHL expression
in the larval trachea leads to excess terminal cell branching in a
manner quite similar to that observed in fga mutants. Molecular and
genetic data indicate that excess btl transcription is a major cause of
hypoxia-induced tracheal phenotypes. Consistent with this, mutations
in the archipelago (ago) gene, which antagonizes btl transcription in
tracheal fusion cells (Mortimer andMoberg, 2007), synergize strongly
with dVHL inactivation to disrupt tracheal migration and branching.
Interestingly, ago mutations also lower the threshold of hypoxia
required to elicit tracheal phenotypes in the ‘early’ embryo, suggesting
that the relative activity of the btl promoter can affect hypoxic
sensitivity. These ﬁndings show that the dVHL/sima pathway plays an
important role in tracheal development, and identify two distinct
phases of embryonic development that show different phenotypic
outcomes of activating this pathway: an early phase during which
sima activity conﬂicts with developmental control of tracheal
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system uses the dVHL/sima/btl pathway to adapt to hypoxia by
increasing its future capacity to deliver oxygen to target tissues.
Materials and methods
Stocks, genetics and statistics
The dVHL open reading framewas cloned as a PCR product into the
EcoRI site of the pSymp vector (Giordano et al., 2002) and used toFig. 1. Tracheal morphogenesis defects following exposure to hypoxia. (A) Schematic represe
(DT) fusion cells (in red). (B–F) Lateral images ofw1118 embryos stained with the tracheal lum
dorsal up. (B) Tracheal architecture of a normoxic embryo. The DT, dorsal branches (DBs), late
showing characteristic phenotypes following exposure to 0.5% O2. (C) Early hypoxic exposure
hypoxic exposure. (E, F) Late hypoxic exposure also causes duplications of the (E) VB an
penetrance of tracheal defects in the indicated hypoxic conditions and genotypes (⁎pb0.001
indicated hypoxic conditions relative to normoxic control, showing a graded hypoxic respogenerateUAS-dVHLi stocks (D. Rennie, Massachusetts General Hospital
Transgenic Drosophila Core). Other strains used in this study were:
ago1, ago3 (Moberg et al., 2001), UAS-agoΔF (Mortimer and Moberg,
2007), btl-Gal4 (Shiga et al., 1996), UAS-sima (Lavista-Llanos et al.,
2002), UAS-btl:GFP (Dammai et al., 2003), UAS-Adf1RNAi (Vienna Dro-
sophila RNAi Center), UAS-pigeonRNAI (NIG-Fly, National Institute of
Genetics, Japan), bnlP1, btldev1, btlEY01638, trh10512, actin-Gal4, UAS-
Ras85D.V12, UAS-pnt.P1, w1118, sima07607, Df(3R)BSC502, esg-lacZ, en-
Gal4, GMR-Gal4 and Exel6060 (all from the Bloomington Drosophila
Stock Center). Embryos were genotyped using the TM6B,P{iab-2(1.7)ntation of severity and timing of hypoxic challenges, relative tomigration of dorsal trunk
en marker mAb2A12. Unless otherwise indicated, embryos are shown anterior left, and
ral trunk (LT) and visceral branches (VBs) are indicated. (C–F) Hypoxia treated embryos
leads to defects in tracheal morphogenesis. (D) Sinuous overgrowth seen following late
d (F) DB within given segment. ‘Extra’ branches are indicated. (G) Quantiﬁcation of
relative to w1118 embryos in 0.5% O2 [blue bars]). (H) Quantiﬁcation of DT length in the
nse (⁎pb0.005; error bars are ±standard error of the mean [SEM]).
Table 1
Genotype Total penetrance (%)a Migration defects (%)b n
Hypoxia-induced embryonic tracheal phenotypes
Normoxia
wt 9 3 61
0.5% O2
wt, stage 11 99 86 45
sima07607, stage 11 16⁎ 8⁎ 39
wt, stage 15 97 0 27
sima07607, stage 15 19⁎ 0 26
1% O2
wt, stage 11 12 5 42
ago3/+, stage 11 41⁎⁎ 9 58
wt, stage 15 74 0 34
ago3/+, stage 15 71 0 35
Tracheal RNAi phenotypes
btl-Gal4:UAS-Adf1i 15 10 59
btl-Gal4:UAS-pigi 16 8 25
btl-Gal4:UAS-dVHLi4B2 60⁎⁎⁎ 16 32
btl-Gal4:UAS-dVHLi11A2 50⁎⁎⁎ 18 34
btl-Gal4:UAS-dVHLi34B3 68⁎⁎⁎ 32⁎⁎⁎ 48
btl-Gal4:UAS-dVHLi4B6 54⁎⁎⁎ 33⁎⁎⁎ 33
btl-Gal4:UAS-dVHLi31A2 61⁎⁎⁎ 38⁎⁎⁎ 40
actin-Gal4:UAS-dVHLi34B3 48⁎⁎⁎ 24⁎⁎⁎ 29
a Refers to tube overgrowth, missing or duplicated secondary branches, excess
terminal cell branching, and migration defects (if evident).
b Refers to interruptions of the DT or LT, or failure of DB midline fusion.
⁎ pb0.01 relative to wt 0.5% O2 values.
⁎⁎ pb0.01 relative to wt 1% values.
⁎⁎⁎ pb0.01 relative to btl-Gal4:UAS-Adf1i.
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and CyO,P{ry+t7.2=lArB} A208.1M2 ‘blue’ balancers, and the CyO,P
{ActGFP}JMR1 balancer (all from the Bloomington Drosophila Stock
Center). Hypoxia treatments were performed using 0.5% O2: 99.5% N2
gas in a hypoxia chamber (Billups-Rothenberg). O2 concentration
within the chamber was monitored by an electronic O2 sensor (RKI
Instruments, Inc., Union City, CA; see Supplementary data). Statistical
comparisons were performed using Student's t-test.
Embryo immunohistochemistry and antibodies
Embryos were staged and ﬁxed as described previously (Mortimer
and Moberg, 2007) and incubated with the following primary
antibodies: mouse anti-Tango (1:2, Developmental Hybridoma Stu-
dies Bank; DSHB), mouse mAb2A12 (1:5, DSHB), rat anti-Trh (1:200,
ref), rabbit anti-β-Gal (1:250, Cappel) and rabbit anti-GFP (1:400,
Molecular Probes). Secondary antibodies conjugated to HRP, AP, Cy3
and FITC were used as recommended (Jackson ImmunoResearch).
Stage 15–16 embryos were analyzed, except where indicated.
Embryos from w1118 and UAS-dVHLi strains crossed to actin-Gal4/
CyO,P{ActGFP}JMR1 were collected at indicated stages and sorted by
the absence of GFP. Whole embryo extracts were prepared in sample
buffer and resolved on 12% SDS-PAGE prior to Western blotting with
anti-dVHL (Arquier et al., 2006) and anti-β-tubulin (1:2000, Santa
Cruz Biotechnology).
RNA analysis
RNA in situ hybridization was performed as described (Merabet
et al., 2005). DIG labeled riboprobes were synthesized from PCR
fragments of btl or bnl cDNA and visualized with anti-DIG-AP
(1:2000, Roche) or anti-DIG-Biotin (1:500, Sigma) followed by TSA-
Biotin ampliﬁcation (PerkinElmer) and incubation with SA-FITC. For
dVHL expression analysis, total RNA was isolated from staged
embryos and reverse-transcribed using random hexamer primers
(Invitrogen) with Superscript II Reverse Transcriptase (Invitrogen).
dVHL and β-tubulin cDNAs were then ampliﬁed with gene-speciﬁc
primers.
Results
Stage-speciﬁc effects of hypoxia on embryonic tracheogenesis
To determine how the embryonic tracheal system responds to
hypoxia, wild type embryos were placed in a reduced oxygen
environment according to the scheme depicted in Fig. 1A. Two
different hypoxic treatments were used: 0.5% O2 for 5 h, or 1% O2
for 4 h. In one set of embryos (denoted ‘early’), hypoxic treatment
was initiated at stage 11 (6–8 h after egg laying; AEL) when dorsal
trunk (DT) branches are actively migrating, and in the other
(denoted ‘late’) it was initiated at stage 15 (13–15 h AEL) when
DT fusion is complete. Following these treatments, embryos were
returned to normoxia (21% O2) and allowed to develop to
embryonic stage 16, at which time tracheal architecture was
visualized with the mAb2A12 tracheal lumen antibody (Figs. 1B–F).
As has been described elsewhere (DiGregorio et al., 2001; Douglas et
al., 2001), embryonic development was arrested by the stronger 0.5%
O2 treatment but resumed upon re-exposure to normoxia. The
weaker hypoxic treatment only led to a slight delay in embryonic
development (data not shown). With very high penetrance (Fig. 1G,
Table 1 and Supplemental Table V), ‘early’ exposure to 0.5% O2
severely stunted DT branch formation and fusion such that adjacent
metameres appear as unconnected lumenal fragments (Fig. 1C).
Structures that form after DT fusion, for example the lateral trunk
(LT), were less severely affected. At an organismal level, ‘early’
hypoxia also resulted in complete lethality prior to hatching (data notshown). In contrast to the stunting effect of ‘early’ hypoxia on
tracheal growth, ‘late’ exposure to 0.5% O2 induced a convoluted tube
overgrowth phenotype throughout the tracheal system (Fig. 1D) at
high penetrance (Fig. 1G, Table 1 and Supplemental Table V). A
similar hypoxia-induced tube overgrowth phenotype has been
reported previously (Arquier et al., 2006). The major primary and
secondary branches of these embryos are highly convoluted and
sinuous, and show visceral branch (VB) and dorsal branch (DB)
duplications (Figs. 1E and F). Unlike the ‘early’ 0.5% O2 treatment,
these ‘late’ embryos showed no signiﬁcant reduction in organismal
viability (data not shown). Interestingly, when these experiments
were repeated under the weaker hypoxic condition of 1% O2, the
overall penetrance of tracheal phenotypes in ‘early’ embryos dropped
considerably (from 97% [n=27] to 12% [n=42]; see Table 1) while
the penetrance of tracheal overgrowth in ‘late’ embryos remained
quite high (Fig. 1G and Table 1). However, comparing DT length in
‘late’ embryos exposed to 1% or 0.5% O2 (Fig. 1H) reveals a progressive
increase in tube length relative to normoxic controls (21±1.1%
longer in 1% O2 [n=4] and 46±3.1% longer in 0.5% O2 [n=4]). Thus
stronger hypoxic challenges produce a progressively stronger
tracheal growth phenotype in the ‘late’ embryo. Overall, these
patterns of tracheal sensitivity to ‘early’ and ‘late’ hypoxia suggest
that hypoxic activation does not always lead to tracheal overgrowth,
but can in fact also stunt tracheal branching during a speciﬁc window
of ‘early’ embryonic development. However, the ‘early’ embryonic
tracheal system is relatively resistant to these effects, while the ‘late’
embryonic tracheal system is sensitized to graded activation of the
hypoxic response pathway.
To test whether sima is responsible for both ‘early’ and ‘late’
hypoxic tracheal phenotypes, embryos homozygous for the sima07607
loss-of-function allele (Centanin et al., 2005) were exposed to the
‘strong’ 0.5% O2 hypoxic challenge at ‘early’ and ‘late’ time points. In
both cases lack of wild type sima strongly suppressed the penetrance
of the hypoxia-induced tracheal phenotypes (Fig. 1G and Table 1),
indicating that activation of the sima hypoxia response pathway in
early stage embryos blocks tracheal cell migration and fusion, while in
later stage embryos it promotes tracheal overgrowth and excess
secondary branching.
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By analogy to mammalian HIF-1α, dVHL-dependent degradation is
predicted to be one of the major mechanisms that restricts sima
activity in normoxia. Indeed analysis of fga mutants suggests that
preventing dVHL from acting on Sima protein speciﬁcally within larval
tracheal cells is a required element of the organismal response to
hypoxia (Centanin et al., 2008). To explore its possible role in
regulating the embryonic hypoxic response, dVHL expression was
assayed during embryogenesis by reverse transcriptase-PCR (RT-PCR,
Fig. 2A). dVHLmRNA is detected throughout embryonic development,
beginning prior to the onset of tracheal development (stages 1–8, Fig.
2A lane 1) and continuing throughout early (stages 9–11), mid (stages
12–14) and late (stages 15–17) tracheogenesis (Fig. 2A lanes 2–4,
respectively), with an apparent peak of expression during mid
tracheogenesis. This is consistent with a role for dVHL in regulating
sima, which is ubiquitously expressed during embryogenesis
(Nambu et al., 1996). Because of a lack of available genomic alleles
of dVHL, we consequently used a transgenic RNA interference (RNAi)
approach to test the role of dVHL in tracheal morphogenesis. A dVHL
RNAi transgene was constructed by inserting a DNA fragment
corresponding to the single dVHL exon into the pSymp vector
(Giordano et al., 2002). Flanking UAS sites allow for Gal4-driven
production of a dVHL dsRNA that is processed by the Drosha/Dicer
pathway into small interfering RNAs (Kim et al., 2006). Multiple UAS-
dVHLi lines were generated and tested for knockdown efﬁciency by
Western blot of dVHL protein in animals expressing the ubiquitousFig. 2. Tracheal-speciﬁc knockdown of dVHL leads to defects in embryonic tracheal morpho
embryonic stages 1–8 (lane 1), 9–11 (lane 2), 12–14 (lane 3) and 15–17 (lane 4). (B) Weste
control embryos (wt) and embryos expressing the indicated combination of actin-Gal4 and U
(H) dorsal images of embryos stained with the tracheal lumen marker mAb2A12. (C) Normal
indicated genotypes showing the range of tracheal defects seen following btl-Gal4:UAS-dVHL
and (H) DBs as indicated. (I, J) Lateral images of (I) w1118 and (I) btl-Gal4:UAS-dVHLi31A2 emb
trachea showing DT interruption, and missing (asterisk) or duplicated (arrows) DBs.‘driver’ actin-Gal4 (Fig. 2B). A range of knockdown efﬁciencies was
observed, ranging from strong (line i31A2) to mild reduction (lines
i11A2 and i34B3) of dVHL protein levels (Fig. 2B).
To determine what role dVHL plays in embryonic tracheal
development, UAS-dVHLi transgenes were expressed in embryos
using either the ubiquitous actin-Gal4 driver or the tracheal cell-
speciﬁc btl-Gal4 driver (Shiga et al., 1996). Because each had a
similar effect on tracheal patterning (Table 1), btl-Gal4 was used for
subsequent experiments. All dVHLi lines had effects on tracheal
development that were not observed in control embryos expressing
RNAi against the neuronal genes Adf1 or pigeon (Fig. 2C and Table
1) or in embryos expressing dVHLi in non-tracheal tissue with the
en-Gal4 driver (data not shown). Expression of the strongest dVHLi
line, i31A2, produced migration defects in a signiﬁcant percentage of
embryos (Fig. 2D) that resemble the effect of ‘early’ hypoxic
challenge on DT migration, but are more severe in that they also
include defective DB/VB migration and interruptions of the LT.
Examination of the fusion cell marker esg-lacZ in this background
reveals that individual LacZ-positive fusion cells are detectable in
tracheal segments that display migration defects (Supplemental Fig.
S4), indicating that loss of dVHL does not prevent cells from
adopting the fusion cell fate. However, because the altered
morphology of these btl-Gal4;dVHLi31A2 makes it difﬁcult to
determine absolute DT fusion cell numbers, we cannot be sure
that fusion cells are speciﬁed normally in all segments. By contrast
to i31A2, expression of the more mild dVHLi knockdown lines leads
to an intermediate phenotype characterized by fewer migration andgenesis. (A) RT-PCR analysis of dVHL (top) and β-tubulin (bottom) expression during
rn blot analysis of dVHL (top panel) levels in whole embryo extracts from stage 13–16
AS-dVHLi lines. α-β-Tubulin is used a loading control (bottom panel). (C–G) Lateral and
tracheal architecture in a btl-Gal4-UAS-Adf1 control RNAi embryo (D–F) Embryos of the
i knockdown. (G,H) btl-Gal4 driven dVHL knockdown also causes duplications of (G) VBs
ryos stained with α-Tgo to mark tracheal cells. (J) Magniﬁed view of a dVHLi embryonic
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and sinuous overgrowth of the primary and secondary branches
that resembles the ‘late’ response to hypoxia (Fig. 2F). dVHL
knockdown also produces overgrown and intertwined secondary
branches (Figs. 2G, H) and secondary branch duplication (Fig. 2J)
similar to that observed in wild type embryos exposed to ‘late’
hypoxia (see Supplemental Table V for a summary of embryonic
phenotypes). In all combinations of btl-Gal4 driver and UAS-dVHLi
transgene, a majority of animals develop through larval stages and
die as pupae (Fig. 4B and Supplemental Table IV), indicating that
persistent knockdown of dVHL in tracheal cells eventually leads to
organismal death. This pupal lethality is speciﬁc to tracheal
expression and is not seen in pupae expressing dVHLi with other
tissue speciﬁc Gal4 drivers (e.g. en-Gal4 or GMR-Gal4; KHM and
NTM unpublished). During the 3rd instar, these larvae show
increases in thick terminal branches (TTBs) (Figs. 3A, C) that can
be phenocopied by exposing larvae to 1% O2 [Fig. 3B; TTBs
quantiﬁed in Supplemental Table III as in (Centanin et al., 2008)].
They also show duplication of larval tertiary branches (see LG
branches in Fig. 3E), and failure of lateral trunk fusion associated
with cells terminating in multiple, ﬁne extensions (Fig. 3F). dVHL is
thus required within tracheal cells to pattern embryonic and larval
tracheal development, and loss of the gene in these cells is sufﬁcient
to mimic the systemic effect of hypoxia on the embryonic and larval
tracheal systems.Fig. 3. Tracheal cell-speciﬁc dVHL knockdown causes defects in terminal cell branching an
showing ramiﬁed branches of a dorsal branch terminal cell from tracheal segment 3 (Tr3). Th
driven expression of UAS-dVHLi31A2. (D–F) Lateral images of third instar larvae. (D) Image
connective (TC), lateral trunk (LT), and LT terminal cells LF, LG and LH are indicated. btl-Gal4:
branches are indicated. (F) btl-Gal4 driven dVHLi31A2 knockdown also causes defects in migra
at the point indicated by the asterisk, but instead fail to fuse leading to the ramiﬁcation ofdVHL genetically antagonizes sima in the embryonic trachea
Stronger dVHL knockdown correlates with more disruptive effects
on primary and secondary branch migration and fusion in a manner
similar to ‘early’ hypoxia, while less efﬁcient knockdown produces a
higher penetrance of tracheal overgrowth and excess branching in a
manner similar to ‘late’ hypoxia. Given the graded tracheal pheno-
types produced by 0.5% and 1% O2 exposure, this range of dVHLi
phenotypes seems very likely to reﬂect variable efﬁciency of dVHL
knockdown. These data thus suggest that chronic activation of sima in
the embryonic tracheal placodes impairs subsequent tracheal migra-
tion and fusion events, while more mild activation of sima leads to
excess tracheal cell branching and growth later in embryonic
development. Analysis of tracheal architecture in btl-Gal4,UAS-sima
embryos conﬁrms that overexpression of exogenous sima is sufﬁcient
block placode branching and migration in the embryo (Supplemental
Fig. 1). To test whether endogenous sima is in fact required to promote
both types of dVHLi tracheal phenotypes, the btl-Gal4 driver was used
to drive the dVHLi lines in the tracheal systems of sima07607/+ or
sima07607/sima07607 embryos (Fig. 4), which can survive up to and
through the pupal phase (Centanin et al., 2005 and our observations).
Initial analysis on was performed on multiple dVHLi lines, all of which
gave a similar result (Fig. 4A and data not shown). As expected based
on the evolutionarily conserved relationship between VHL and HIF-
1α, removing one copy of sima signiﬁcantly reduced the penetrance ofd larval tracheal morphology. (A–C) Bright-ﬁeld dorsal images of third instar larvae
ick terminal branch (TTB) number is increased by (B) exposure to 1% O2 or (C) btl-Gal4
of a single segment from a normoxic larva. The ganglionic branch (GB), transverse
UAS-dVHLi31A2 expression leads to duplications of lateral trunk terminal cells. (E) Two LG
tion/fusion of secondary branches. The LT branches from adjacent placodes should fuse
multiple ﬁne tracheal branches.
Fig. 4. dVHL knockdown phenotypes genetically require sima. (A) Penetrance of
tracheal defects in embryos with btl-Gal4 driven expression of UAS-Adf1i or the UAS-
dVHLi34B3 transgene. dVHLi phenotypes are suppressed by sima alleles in a dose-
dependent manner (⁎pb0.001 relative to btl-Gal4:UAS-dVHLi34B3). (B) Frequency of
pupal lethality in the indicated genotypes. btl-Gal4:UAS-dVHLi34B3 lethality is dom-
inantly suppressed by sima or Df(3R)BSC502 (⁎pb0.005 relative to btl-Gal4:UAS-
dVHLi34B3; error bars are ±SEM).
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(Fig. 4A and Supplemental Table I). Moreover, removing the remaining
wild type copy of sima further suppressed the frequency of dVHLi34B3
tracheal phenotypes to background levels equivalent to that seen in
control btl-Gal4,UAS-Adf1i RNAi embryos, indicating that sima is
absolutely required for dVHLi tracheal phenotypes. Reducing sima
gene dosage by half is also sufﬁcient to completely suppress the pupal
lethality of the btl-Gal4,UAS-dVHLi34B3 genotype back to adult viability
(Fig. 4B and Supplemental Table IV). Heterozygosity for a genomic
deletion removing the sima locus (Df(3R)BSC502) is also sufﬁcient to
suppress dVHLi34B3 pupal lethality (Fig. 4B and Supplemental Table IV)
suggesting the ability of the sima07607 allele to suppress dVHLi
phenotypes is due to loss of sima rather than some cryptic mutation
in the background. These strong genetic interactions between dVHL
and sima validate the speciﬁcity of the UAS-dVHLi system as a
technique to antagonize dVHL activity in vivo, and indicate that sima
is a major effector of the morphological changes that occur in the
embryonic tracheal system in response to either reduced oxygen
availability or loss of dVHL.
dVHL suppresses btl expression in the embryo
By analogy to the larval tracheal system in which sima-driven
expression of the btl FGF receptor induces excess growth and
branching of terminal cells (Centanin et al., 2008), we next sought
to determine whether both aspects of dVHLi embryonic tracheal
phenotype – defective migration and sinuous overgrowth and
branching – were also dependent on Btl/FGF signaling. Recessive
lethal alleles of the btl receptor (btldev1) (Kennison and Tamkun,
1988), the bnl ligand (bnlP1) (Sutherland et al., 1996), and the trh
bHLH-PAS transcription factor responsible for induction of btl
expression in the tracheal placode (trh10512) (Wilk et al., 1996), were
placed in the background of btl-Gal4,UAS-dVHLi34B3. Embryonic
tracheal architecture was analyzed with the mAb2A12 antibody and
the fraction of embryos showing either migration defects or excess
growth/branching defects was calculated as a percentage of the total(Fig. 5A and Supplemental Table I). Loss of one copy of either btl or bnl
led to a signiﬁcant reduction in the penetrance of dVHLi34B3 tracheal
phenotypes from 68% (n=48) to 26% (n=54) and 25% (n=55)
respectively, comparable to heterozygosity for the sima07607 allele.
Tracheal phenotypes that result from reduced dVHL activity thus
display equal sensitivity to reductions in Btl signal strength or to
reduced activity of the btl transcriptional activator Sima. This
sensitivity might reﬂect a role for dVHL as an antagonist of a pathway
that operates in parallel to Btl or a role for dVHL as a direct antagonist
of Btl (Hsu et al., 2006), although dVHL inactivation had little effect on
the levels or trafﬁcking of a Btl:GFP fusion protein (Supplemental Fig.
2). Precedent with the larval function of the HPH fga suggests that
dVHLmay act through Sima to control btl transcription in the embryo
more directly (Centanin et al., 2008). Consistent with this hypothesis,
expression of a wild type btl transgene speciﬁcally in tracheal cells
produces tracheal overgrowth (Fig. 5B), DT breaks (Mortimer and
Moberg, 2007), and excess larval TTBs (Supplemental Table III) that
resemble dVHLi tracheal-speciﬁc knockdown phenotypes. A constitu-
tively active btl allele (btlλ) has previously been shown to block early
migration events in the embryonic tracheal system and also lead to
secondary branch duplication (Lee et al., 1996b). Moreover, expression
of either of two downstream effectors of Btl – Ras85D (Lee et al.,
1996a) or the pnt transcription factor (Klaes et al., 1994) – disrupts
tracheal branching in the embryo (Figs. 5C, D). To test whether dVHL
restricts btl transcription in vivo, we ﬁrst made use of the prior
observation that ubiquitous overexpression of sima in the embryo is
sufﬁcient to induce speciﬁc groups of non-tracheal cells to form
ectopic btl-positive placodes (Centanin et al., 2008). sima can induce
two ectopic placodes (tp1 and tp0) anterior to the ﬁrst tracheal
placode (tp1), and occasionally a third (tp11) distal to the last placode
(tp10). These cryptic placodes also appear in response to trh (Wilk et
al., 1996) and appear to be primed to adopt a tracheal fate by spatially
restricted signals like vvl (Boube et al., 2000; Zelzer and Shilo, 2000a)
that sensitize the btl promoter to other trans-activators. Signiﬁcantly,
ubiquitous knockdown of dVHL leads to the appearance of an ectopic
btl-positive placode at the tp0 position (Figs. 5F, G). At lower
frequency btl-expressing cells also appear at the tp1 and tp11
positions as well (Supplemental Fig. 3). Loss of dVHL is thus capable
of mimicking the effect of trh or sima overexpression on patterns of btl
transcription. Expression of Trh protein in this genetic background
remains restricted to placodes 1–10 (Fig. 5P), again supporting the
notion that expression of dVHLi leads speciﬁcally to sima-mediated
phenotypes. To test whether reduced dVHL activity also results in
higher levels of btl transcription in differentiated tracheal cells, UAS-
dVHLi/+ and UAS-dVHLi/btlGal4,UAS-GFP embryos at either stage 11
(pre-migratory) or stage 15 (post-migratory) were hybridized with a
btl RNA probe and developed using a tyramide-ampliﬁcation protocol
(Merabet et al., 2005). Samples from each stage were processed
together and genotyped afterward by GFP expression. At stage 11,
levels of btl transcript are elevated in tracheal placodes expressing the
dVHLi knockdown transgene compared to control embryos (Figs. 5I vs.
5M). Similarly stage 15 embryos carrying the dVHLi knockdown
transgene show increased levels of btl transcript in cells of the DT, the
DBs, and the transverse connectives (Figs. 5K vs. 5O). dVHL thus
restricts btl transcription in tracheal cells at multiple stages of
embryonic development. In view of the genetic requirement for btl
in dVHLi tracheal phenotypes, these data indicate that Sima-driven
elevation in btl expression and activity is a major cause of both the
‘early’ and ‘late’ tracheal responses to hypoxia.
dVHL and ago synergize to control embryonic tracheogenesis
The sima and trh transcription factors are each capable of
interacting with the btl promoter to induce btl expression in
cultured cells (Centanin et al., 2008; Ohshiro and Saigo, 1997).
Previous work has shown that trh alleles dominantly suppress
Fig. 5. dVHLi expression leads to ectopic btl transcription. (A) Penetrance of tracheal defects in embryos with btl-Gal4 driven expression of UAS-Adf1i control RNAi or the UAS-
dVHLi34B3 transgene in tracheal cells. btl-Gal4:UAS-dVHLi34B3 phenotypes are dominantly suppressed by alleles of the FGF pathway components btl or bnl, but not by alleles of the
transcription factor trh (⁎pb0.001 relative to btl-Gal4:UAS-dVHLi34B3). (B–D) Lateral images of embryos stained with the tracheal lumen marker mAb2A12. btl-Gal4:UAS-dVHLi34B3
phenotypes are phenocopied by btl-Gal4 driven overexpression of (B) btl, or FGF downstream pathway components (C) Ras85D.V12 (a constitutively active form of Ras85D), or (D)
the MAPK transcriptional effector pnt.P1. (E–G) Lateral images of embryos hybridized with a btl anti-sense probe. (E) Control actin-Gal4 embryos display the normal complement of
ten btl-positive tracheal placodes (tp1 through tp10). (F, G) actin-Gal4 driven expression of dVHLi31A2 causes ectopic transcription of btl in cryptic tracheal placodes (indicated as
tp0). Control UAS-dVHLi31A2 stage 11 (H, I) and stage 15 (J, K) embryos hybridized with a btl anti-sense probe and stained with α-GFP. btl is expressed in all cells of stage 11 tracheal
placodes, but only in migrating tracheal cells of stage 15 embryos. UAS-dVHLi31A2/btl-Gal4,UAS-GFP stage 11 (L, M) and stage 15 (N, O) embryos hybridized with a btl anti-sense probe
and stained with α-GFP, showing elevated btl expression. Embryos were genotyped by expression of GFP. Arrowhead indicates DT. (P) Stage 11 actin-Gal4:UAS-dVHLi31A2 embryo
stained with α-Trh. Trh staining shows the wild type pattern of ten Trh positive tracheal placodes (tp1 through tp10).
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DT fusion cells lacking the archipelago (ago) gene, which encodes an
F-box protein that binds Trh and recruits it into a SCF ubiquitin
ligase complex for polyubiquitination and proteasome-dependent
degradation (Moberg et al., 2001; Mortimer and Moberg, 2007).
Thus the observations that dVHLi tracheal phenotypes require sima
but are only minimally sensitive to trh gene dosage (Fig. 5A and
Supplemental Table I) and that Trh expression is not altered by loss
of dVHL (Fig. 5P), suggests that the ago and dVHL ubiquitin ligasesrestrict btl expression by genetically distinct pathways. To test if
dVHL and ago alleles might then collaborate to deregulate btl-
dependent branching and migration events, the frequency of the
two types of dVHLi embryonic tracheal phenotypes – stunted
migration or ectopic branching and sinuous overgrowth – were
examined in a background heterozygous for the ago3 strong loss-of-
function allele (Moberg et al., 2001). Two ‘weaker’ dVHL lines (i11A2
and i4B2) that gave a higher frequency of sinuous overgrowth and a
somewhat lower frequency of migration defects were used for this
302 N.T. Mortimer, K.H. Moberg / Developmental Biology 329 (2009) 294–305analysis. In both cases, addition of the ago allele shifts the most
frequent tracheal phenotype from sinuous overgrowth to stunted
branch migration (Figs. 6A, B) and increases the overall fraction of
embryos with migration defects to 70–75% (Fig. 6C and Supple-
mental Table II). Moreover, embryos trans-heterozygous for the ago3
allele and a genomic deﬁciency that removes the dVHL locus
(Exel6060/+;ago3/+) show an elevated frequency of tracheal fusion
and migration defects compared to either lesion alone (Figs. 6D, E).
The dVHL deﬁciency also dominantly enhances the number of DT
breaks per affected ago1/ago3 embryo from 1.2±0.09 (n=39) to
2.5±0.19 (n=41) (pb1×10−6) (Figs. 6F, G). Thus, dVHL and ago
act synergistically to control migration and fusion events in the
developing tracheal system. Interestingly, examination of L3 larvae
that co-express dVHLi31A2 and a dominant-negative form of ago
(UAS-agoΔF) (Mortimer and Moberg, 2007) in tracheal cells shows
no enhancement of TTB branching beyond that observed with dVHL
knockdown alone (Supplemental Table III). The synergy between
ago and dVHL may thus be speciﬁc to the early embryonic tracheal
system. To test whether the functional interaction between dVHL
and ago is indeed speciﬁc to a particular developmental phase, the
‘weaker’ dose of 1% O2 was used as a switch to activate the dVHL/
sima transcriptional program at ‘early’ or ‘late’ embryonic timeFig. 6. ago interacts with dVHL in tracheal morphogenesis. (A–D) Lateral views of embryos st
enhanced by reducing the genetic dosage of ago (B). (C) Enhancement of the penetrance of m
btl-Gal4:UAS-dVHLi alone). (D–G) Alleles of ago also interact with a deletion (Exel6060) unco
mAb2A12 displaying defects in tracheal morphogenesis. (E) Quantiﬁcation of the trans-h
compared to wt). (F) Lateral view of an Exel6060/+;ago1/3 embryo stained with mAb2A12.
tracheal phenotype by Exel6060. (H) Penetrance of all classes of tracheal defects (breaks,
exposure to 1% O2. (⁎pb0.005 relative to w1118).points (according to the scheme depicted in Fig. 1) in either wild
type (+/+) embryos or ago3/+ embryos. Tracheal architecture was
then analyzed with mAb2A12. As described above (Fig. 1G), ‘early’
exposure to 1% O2 produces tracheal phenotypes at fairly low
penetrance (12%). Signiﬁcantly, reducing the dose of ago leads to a
more than 3-fold increase in the penetrance of tracheal phenotypes
in response to this 1% O2 treatment (Fig. 6H and Table 1). This
includes an approximate doubling of migration defects (from 5% to
9% of embryos), appearance of duplicated secondary branches (from
0% to 5% of embryos), and an increase in sinuous overgrowth (from
2% to 34% of embryos). Notably, this enhancement is speciﬁc to the
‘early’ time point: exposure to 1% O2 at the ‘late’ embryonic time
point produced the same penetrance of tracheal phenotypes in
ago3/+ and control +/+ embryos (Fig. 6H and Table 1). Moreover,
ago heterozygosity did not affect the extent of DT growth induced in
response to ‘late’ 1% O2 (21±3.1% longer in +/+, n=4, [see yellow
bar in Fig. 1H]; 20±2.6% longer in ago3/+, n=4), demonstrating
that a phenotype that is a dose-sensitive readout of pathway activity
is also unaffected by lowered ago activity. Reducing ago activity
thus speciﬁcally sensitizes the ‘early’ embryonic tracheal system to
architectural changes in response to milder doses of hypoxia. As ago
restricts btl transcription in the developing embryonic trachealained with the lumenal marker mAb2A12. The btl-Gal4:UAS-dVHLi11A2 phenotype (A) is
igration defects in btl-Gal4:UAS-dVHLi embryos by the ago3 allele (⁎pb0.05 compared to
vering the dVHL locus. (D) Lateral view of an Exel6060/+;ago3/+ embryo stained with
eterozygous interaction between ago and Exel6060 in tracheal formation (⁎pb0.001
(G) Frequency of embryos with 1, 2, or 3+ DT breaks shows enhancement of the ago1/3
overgrowth, missing or duplicated branches) in w1118 and ago3/+ embryos following
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between ago and hypoxia appears to deﬁne a window of develop-
ment during which activation of the dVHL/sima pathway induces a
program of gene expression that conﬂicts with normal btl/bnl
migration cues. Removing a copy of ago is predicted to enhance this
conﬂict by elevating Trh activity and btl transcription.
Discussion
Hypoxia-induced remodeling of tracheal terminal cells represents
the response of a developed larval tracheal system to reduced levels of
O2 in the environment. By contrast, the response of the developing
embryonic tracheal system to systemic hypoxia has not been as well
characterized. In light of the observation that embryonic tracheal cells
display hypoxia-induced activation of a Sima-reporter (Lavista-Llanos
et al., 2002) and that sima promotes btl expression in larval tracheal
cells (Centanin et al., 2008), embryonic exposure to hypoxia may thus
produce a situation in which hard-wired btl/bnl patterning signals in
the embryo come into conﬂict with the type of sima/btl-driven
plasticity of tracheal cell branching seen in the larva. Here we examine
the effect of hypoxia on embryonic tracheal branching and migration.
We ﬁnd that hypoxia has dramatic effects on the patterns of
morphogenesis of the primary and secondary tracheal branches.
Surprisingly, varying the timing and severity of hypoxic challenge is
able to shift the outcome from severely stunted tracheal branching to
excess branch number and enhanced branch growth. Genetic and
molecular data indicate that both classes of phenotypes, stunting and
overgrowth, involve regulation of sima activity and btl transcription
by dVHL, and that the effects of hypoxia on tracheal development can
be mimicked in normoxia by tracheal-speciﬁc knockdown of dVHL.
This observation conﬁrms a central role for dVHL in restricting the
hypoxic response in vivo, and identiﬁes a role for dVHL as a required
inhibitor of sima and btl during normal tracheogenesis.
Since Trh and Sima/HIF-1α share a similar consensus DNA binding
site (Jiang and Crews, 2007; Gorr et al., 2004; Crews and Fan, 1999), it
is likely that the tracheal phenotypes elicited by either hypoxia or
dVHL knockdown are to some degree the product of a combined
‘Trh/Sima-like’ transcriptional activity in tracheal cells. This conclu-
sion is supported both by the general phenotypic similarity (i.e.
migration and overgrowth defects) between hypoxia/dVHL knock-
down and trh overexpression (Mortimer and Moberg, 2007), by the
modest ability of trh alleles to suppress dVHLi phenotypes, and by the
previously demonstrated overlap of transcriptional activity between
Trh and human HIF-1α (Zelzer et al., 1997). Indeed, Trh is well-
established as a required activator of developmental btl expression.
However, because the excess Btl activity that occurs in hypoxia or in
the absence of dVHL occurs independently of a change in Trh
expression (Fig. 5P), it thus appears to be mediated largely by
increased sima activity.
Our analysis suggests that there are two distinct developmental
‘windows’ of embryogenesis during which hypoxia has opposite
effects on tracheal branching. The ﬁrst corresponds to a period
immediately before and during primary branch migration that is
relatively insensitive to hypoxia. Embryos in this stage show a
minimal response to 1% O2, but show a nearly complete arrest of
migration in 0.5% O2. Interestingly, a prior study found that similarly
staged embryos (stage 11) respond to complete anoxia by prolonged
developmental arrest, from which they can emerge and resume
normal development (Wingrove and O'Farrell, 1999). These some-
what paradoxical results – that acute hypoxia is more detrimental to
development than chronic anoxia – might be explained by the
observation that chronic exposure to low O2 induces Sima activity
throughout the embryo while acute exposure activates Sima only in
tracheal cells (Lavista-Llanos et al., 2002). The former scenario may
result in coordinated developmental and metabolic arrest throughout
the organism, while in the latter scenario developmental patterns ofgene expression in non-tracheal cells may proceed such that tracheal
cells emerging from an ‘early’ hypoxic response ﬁnd an embryonic
environment in which developmentally hard-wired migratory signals
emanating from non-tracheal cells have ceased.
The second type of tracheal response occurs during a later
‘window’ of embryogenesis after btl/bnl-driven primary and second-
ary branch migration and fusion are largely complete. It involves
sinuous overgrowth of the primary and secondary branches (this
study and Arquier et al., 2006), and duplication of secondary branches.
As in the ‘early’ response, ‘late’ hypoxic phenotypes are controlled by
the dVHL/sima pathway, yet unlike the ‘early’ response, these
phenotypes occur at high penetrance even at 1% O2. Thus the ‘late’
embryonic tracheal system is relatively sensitized to hypoxia and
responds with increased branching in a manner similar to larval
terminal cells. Indeed, much as larval branching increases with
decreasing O2 levels (Jarecki et al., 1999), we observe that dorsal
trunk growth in the late embryo is graded to the degree of hypoxia.
The mechanism underlying the differential sensitivity of the ‘early’
and ‘late’ tracheal system may be quite complex. However, we ﬁnd
that tracheogenesis can be sensitized to hypoxia by reducing activity
of ago, a ubiquitin ligase component that restricts btl transcription in
tracheal cells via its role in degrading the Trh transcription factor
(Mortimer and Moberg, 2007). Increasing transcriptional input on the
btl promoter thus appears to sensitize ‘early’ tracheal cells to hypoxia.
As Sima also controls btl transcription, one explanation of the
difference in sensitivity between different embryonic stages may
thus lie in differences in the activation state of the btl promoter. If so
then the activity of the endogenous btl regulatory network (Boube et
al., 2000; Kuhnlein and Schuh, 1996; Llimargas and Casanova, 1997;
Mortimer and Moberg, 2007; Ohshiro et al., 2002; Ohshiro and Saigo,
1997; Samakovlis et al., 1996; Zelzer and Shilo, 2000b) may be an
important determinant of the threshold of hypoxia required to elicit
changes in tracheal architecture.
An organism can have its hypoxic response triggered in two ways,
either by systemic exposure of the whole organism to a reduced O2
environment or by localized hypoxia produced by increased O2
consumption in metabolically active tissues. Data from this study
and others (Centanin et al., 2008; Jarecki et al., 1999) suggests there
may be distinctions between these two triggers. Exposing larvae or
embryos to a systemic pulse of hypoxia results in a ‘btl-centric’
response speciﬁcally in tracheal cells. Outside of an ‘early’ vulnerable
period which corresponds to embryonic branch migration and fusion,
elevated Btl activity in embryonic tracheal cells promotes branch
duplications and overgrowth similar to that seen in larvae (Centanin
et al., 2008). By contrast, tracheal growth induced by localized hypoxia
in the larva has been suggested to involve a ‘bnl-centric’ model in
which the hypoxic tissue secretes Bnl and recruits new tracheal
branching (Jarecki et al., 1999). Whether this type of mechanism
operates in embryos, or whether embryos ever experience localized
hypoxia in non-tracheal cells, has not been established.
Our data indicate that dVHL is a central player in the hypoxic
response pathway in embryonic and larval tracheal cells. A prior study
found that injection of dVHL dsRNA into syncytial embryos disrupted
normal tracheogenesis (Adryan et al., 2000), but was technically
limited in its ability to conduct a detailed analysis of dVHL function in
development and homeostasis. We ﬁnd that dVHL knockdown
speciﬁcally in tracheal cells mimics the effect of systemic hypoxia on
embryonic tracheal architecture and larval terminal cell branching.
dVHL knockdown thus phenocopies loss of the HPH gene fga, which
normally functions to target Sima to the dVHL ubiquitin ligase in
normoxia (Centanin et al., 2005). Moreover, all phenotypes that result
from reduced dVHL expression can be rescued by reducing sima
activity, suggesting that Sima is the major target of dVHL in the
tracheal system. These data support a model in which dVHL, fga, and
sima function as part of a conserved VHL/HPH/HIF-1α pathway to
control tracheal morphogenesis in embryos and larvae. The btl
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embryonic (this study) and larval (Centanin et al., 2008) tracheal
cells. Knockdown of dVHL elevates btl transcription in embryonic
placodes and tracheal branches, and removal of a copy of the gene
effectively suppresses dVHL tracheal phenotypes. Reciprocally, over-
expression of wild type btl in embryonic tracheal cells can produce
migration defects and sinuous overgrowth (this study and Mortimer
and Moberg, 2007), while expression of a constitutively active btl
chimera (btlλ) also leads to primary branch stunting and duplication
of secondary branches (Lee et al., 1996b). Interestingly, pupal lethality
associated with tracheal-speciﬁc knockdown of dVHL is not sensitive
to the dose of btl, but is dependent on sima. Thus the dVHL/sima
pathway may have btl independent effects on tracheal cells in later
stages of development.
In addition to sima and Btl/FGF pathwaymutants, dVHL also shows
very strong genetic interactions with alleles of the ago ubiquitin ligase
subunit. The interactions are consistent with the ability of ago to
modulate hypoxia sensitivity in the embryo, and suggest a speculative
model inwhich each ligase acts through its own target – Sima or Trh –
to regulate btl transcription in tracheal cells. Given that the human
orthologs of dVHL and ago are signiﬁcant tumor suppressor genes, it is
intriguing to consider whether their ability to co-regulate tubular
morphogenesis in the Drosophila embryo is conserved in mammalian
development and disease.
Acknowledgments
We apologize to those whose work we did not cite due to space
constraints. Wewish to thank P.Wappner, T. Hsu, S. Sanyal, D. Andrew,
M.Csete, and S. Merabet for gifts of reagents and protocols, and S.
Burdick for technical assistance. We thank the Developmental Studies
Hybridoma Bank, the Bloomington Drosophila Stock Center, and the
Drosophila Genomics Resource Center for ﬂy stocks, antibodies and
cDNAs. This work was funded by the American Heart Association
(Predoctoral Fellowship 0715483B to NTM) and the National Institute
of Health (GM079242 to KHM).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2009.03.001.
References
Adryan, B., Decker, H.J., Papas, T.S., Hsu, T., 2000. Tracheal development and the von
Hippel-Lindau tumor suppressor homolog in Drosophila. Oncogene 19, 2803–2811.
Arquier, N., Vigne, P., Duplan, E., Hsu, T., Therond, P.P., Frelin, C., D'Angelo, G., 2006.
Analysis of the hypoxia-sensing pathway in Drosophila melanogaster. Biochem. J.
393, 471–480.
Aso, T., Yamazaki, K., Aigaki, T., Kitajima, S., 2000. Drosophila von Hippel-Lindau tumor
suppressor complex possesses E3 ubiquitin ligase activity. Biochem. Biophys. Res.
Commun. 276, 355–361.
Boube, M., Llimargas, M., Casanova, J., 2000. Cross-regulatory interactions among
tracheal genes support a co-operative model for the induction of tracheal fates in
the Drosophila embryo. Mech. Dev. 91, 271–278.
Centanin, L., Ratcliffe, P.J., Wappner, P., 2005. Reversion of lethality and growth defects
in Fatiga oxygen-sensor mutant ﬂies by loss of Hypoxia-Inducible Factor-alpha/
Sima. EMBO Rep. 6, 1070–1075.
Centanin, L., Dekanty, A., Romero, N., Irisarri, M., Gorr, T.A., Wappner, P., 2008. Cell
autonomy of HIF effects in Drosophila: tracheal cells sense hypoxia and induce
terminal branch sprouting. Dev. Cell 14, 547–558.
Crews, S.T., Fan, C.M., 1999. Remembrance of things PAS: regulation of development by
bHLH-PAS proteins. Curr. Opin. Genet. Dev. 9, 580–587.
Dammai, V., Adryan, B., Lavenburg, K.R., Hsu, T., 2003. Drosophila awd, the homolog of
human nm23, regulates FGF receptor levels and functions synergistically with shi/
dynamin during tracheal development. Genes Dev. 17, 2812–2824.
DiGregorio, P.J., Ubersax, J.A., O'Farrell, P.H., 2001. Hypoxia and nitric oxide induce a
rapid, reversible cell cycle arrest of the Drosophila syncytial divisions. J. Biol. Chem.
276, 1930–1937.
Douglas, R.M., Xu, T., Haddad, G.G., 2001. Cell cycle progression and cell division are
sensitive to hypoxia in Drosophila melanogaster embryos. Am. J. Physiol. Regul.
Integr. Comp. Physiol. 280, R1555–R1563.Ghabrial, A., Luschnig, S., Metzstein, M.M., Krasnow, M.A., 2003. Branching
morphogenesis of the Drosophila tracheal system. Annu. Rev. Cell Dev. Biol. 19,
623–647.
Giordano, E., Rendina, R., Peluso, I., Furia, M., 2002. RNAi triggered by symmetrically
transcribed transgenes in Drosophila melanogaster. Genetics 160, 637–648.
Gorr, T.A., Cahn, J.D., Yamagata, H., Bunn, H.F., 2004. Hypoxia-induced synthesis of
hemoglobin in the crustacean Daphnia magna is hypoxia-inducible factor-
dependent. J. Biol. Chem. 279, 36038–36047.
Gorr, T.A., Gassmann, M., Wappner, P., 2006. Sensing and responding to hypoxia via HIF
in model invertebrates. J. Insect Physiol. 52, 349–364.
Guillemin, K., Groppe, J., Ducker, K., Treisman, R., Hafen, E., Affolter, M., Krasnow, M.A.,
1996. The pruned gene encodes the Drosophila serum response factor and regulates
cytoplasmic outgrowth during terminal branching of the tracheal system.
Development 122, 1353–1362.
Hsu, T., Adereth, Y., Kose, N., Dammai, V., 2006. Endocytic function of von Hippel-Lindau
tumor suppressor protein regulates surface localization of ﬁbroblast growth factor
receptor 1 and cell motility. J. Biol. Chem. 281, 12069–12080.
Jarecki, J., Johnson, E., Krasnow, M.A., 1999. Oxygen regulation of airway branching in
Drosophila is mediated by branchless FGF. Cell 99, 211–220.
Jiang, L., Crews, S.T., 2007. Transcriptional speciﬁcity of Drosophila dysfusion and the
control of tracheal fusion cell gene expression. J. Biol. Chem. 282, 28659–28668.
Kaelin Jr., W.G., 2005. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen
sensing. Biochem. Biophys. Res. Commun. 338, 627–638.
Kaelin Jr., W.G., Ratcliffe, P.J., 2008. Oxygen sensing bymetazoans: the central role of the
HIF hydroxylase pathway. Mol. Cell 30, 393–402.
Kennison, J.A., Tamkun, J.W., 1988. Dosage-dependent modiﬁers of polycomb and
antennapedia mutations in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 85,
8136–8140.
Kim, K., Lee, Y.S., Harris, D., Nakahara, K., Carthew, R.W., 2006. The RNAi pathway
initiated by Dicer-2 in Drosophila. Cold Spring Harb. Symp. Quant. Biol. 71, 39–44.
Klaes, A., Menne, T., Stollewerk, A., Scholz, H., Klambt, C., 1994. The Ets transcription
factors encoded by the Drosophila gene pointed direct glial cell differentiation in
the embryonic CNS. Cell 78, 149–160.
Klambt, C., Glazer, L., Shilo, B.Z., 1992. breathless, a Drosophila FGF receptor homolog, is
essential for migration of tracheal and speciﬁc midline glial cells. Genes Dev. 6,
1668–1678.
Kuhnlein, R.P., Schuh, R., 1996. Dual function of the region-speciﬁc homeotic gene spalt
during Drosophila tracheal system development. Development 122, 2215–2223.
Lavista-Llanos, S., Centanin, L., Irisarri, M., Russo, D.M., Gleadle, J.M., Bocca, S.N.,
Muzzopappa, M., Ratcliffe, P.J., Wappner, P., 2002. Control of the hypoxic response in
Drosophila melanogaster by the basic helix–loop–helix PAS protein similar. Mol. Cell
Biol. 22, 6842–6853.
Lee, T., Feig, L., Montell, D.J., 1996a. Two distinct roles for Ras in a developmentally
regulated cell migration. Development 122, 409–418.
Lee, T., Hacohen, N., Krasnow, M., Montell, D.J., 1996b. Regulated Breathless receptor
tyrosine kinase activity required to pattern cell migration and branching in the
Drosophila tracheal system. Genes Dev. 10, 2912–2921.
Llimargas, M., Casanova, J., 1997. ventral veinless, a POU domain transcription factor,
regulates different transduction pathways required for tracheal branching in Dro-
sophila. Development 124, 3273–3281.
Lubarsky, B., Krasnow, M.A., 2003. Tube morphogenesis: making and shaping biological
tubes. Cell 112, 19–28.
Manalo, D.J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B.D., Ye, S.Q., Garcia, J.G., Semenza,
G.L., 2005. Transcriptional regulation of vascular endothelial cell responses to
hypoxia by HIF-1. Blood 105, 659–669.
Manning, G., Krasnow, M.A., 1993. Development of the Drosophila tracheal system. In:
Bate, M., Martinez Arias, A. (Eds.), The Development of Drosophila melanogaster.
Cold Spring Harbor Press, Cold Spring Harbor, New York, pp. 609–685.
Merabet, S., Ebner, A., Affolter, M., 2005. The Drosophila Extradenticle and Homothorax
selector proteins control branchless/FGF expression in mesodermal bridge-cells.
EMBO Rep. 6, 762–768.
Moberg, K.H., Bell, D.W., Wahrer, D.C., Haber, D.A., Hariharan, I.K., 2001. Archipelago
regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines.
Nature 413, 311–316.
Mortimer, N.T., Moberg, K.H., 2007. The Drosophila F-box protein Archipelago controls
levels of the Trachealess transcription factor in the embryonic tracheal system. Dev.
Biol. 312, 560–571.
Nambu, J.R., Chen, W., Hu, S., Crews, S.T., 1996. The Drosophila melanogaster similar
bHLH-PAS gene encodes a protein related to human hypoxia-inducible factor 1
alpha and Drosophila single-minded. Gene 172, 249–254.
Ohshiro, T., Saigo, K., 1997. Transcriptional regulation of breathless FGF receptor gene by
binding of TRACHEALESS/dARNT heterodimers to three central midline elements in
Drosophila developing trachea. Development 124, 3975–3986.
Ohshiro, T., Emori, Y., Saigo, K., 2002. Ligand-dependent activation of breathless FGF
receptor gene in Drosophila developing trachea. Mech. Dev. 114, 3–11.
Samakovlis, C., Hacohen, N., Manning, G., Sutherland, D.C., Guillemin, K., Krasnow, M.A.,
1996. Development of the Drosophila tracheal system occurs by a series of
morphologically distinct but genetically coupled branching events. Development
122, 1395–1407.
Shiga, Y., Tanaka-Matakatsu, M., Hayashi, S., 1996. A nuclear GFP/beta-galactosidase
fusion protein as a marker for morphogenesis in living Drosophila. Dev. Growth
Differ. 38, 99–106.
Sonnenfeld, M., Ward, M., Nystrom, G., Mosher, J., Stahl, S., Crews, S., 1997. The
Drosophila tango gene encodes a bHLH-PAS protein that is orthologous to
mammalian Arnt and controls CNS midline and tracheal development.
Development 124, 4571–4582.
305N.T. Mortimer, K.H. Moberg / Developmental Biology 329 (2009) 294–305Sutherland, D., Samakovlis, C., Krasnow, M.A., 1996. branchless encodes a Drosophila
FGF homolog that controls tracheal cell migration and the pattern of branching. Cell
87, 1091–1101.
Tsarouhas, V., Senti, K.A., Jayaram, S.A., Tiklova, K., Hemphala, J., Adler, J., Samakovlis, C.,
2007. Sequential pulses of apical epithelial secretion and endocytosis drive airway
maturation in Drosophila. Dev. Cell 13, 214–225.
Wilk, R., Weizman, I., Shilo, B.Z., 1996. trachealess encodes a bHLH-PAS protein that is an
inducer of tracheal cell fates in Drosophila. Genes Dev. 10, 93–102.Wingrove, J.A., O'Farrell, P.H., 1999. Nitric oxide contributes to behavioral, cellular,
and developmental responses to low oxygen in Drosophila. Cell 98, 105–114.
Zelzer, E., Shilo, B.Z., 2000a. Cell fate choices in Drosophila tracheal morphogenesis.
Bioessays 22, 219–226.
Zelzer, E., Shilo, B.Z., 2000b. Interaction between the bHLH-PAS protein Trachealess and
the POU-domain protein Drifter, speciﬁes tracheal cell fates. Mech. Dev. 91,163–173.
Zelzer, E., Wappner, P., Shilo, B.Z., 1997. The PAS domain confers target gene speciﬁcity of
Drosophila bHLH/PAS proteins. Genes Dev. 11, 2079–2089.
